Editorial
I n this issue, Sabayan et al 1 discuss their findings from the AGES-Reykjavik study, on the association between brain atrophy and baseline N-terminal brain natriuretic peptide (NT-proBNP), a marker of cardiac dysfunction, and carotid intima-media thickness (CIMT), a marker of carotid atherosclerosis burden. They found that both higher NT-proBNP and CIMT were associated with longer term decline in total brain and gray matter volume but not with white matter volume. The highest rates of brain volume decline (at ≈3 times that seen in normal ageing) were seen in subjects with both high NT-proBNP and CIMT, and this was independent of age, education, and cardiovascular factors.
See accompanying article on page 2246
Strengths of the study include the longitudinal population (volunteer) design with brain volumes measured both at baseline and after 5 years and the determination of both cardiac and carotid markers in the same large sample. The authors acknowledge the possibility that selection bias may have occurred in that only those who were magnetic resonance imaging-safe and willing and who returned for 5-year magnetic resonance imaging were included, 2 which cannot be corrected by statistical methods. Also, although adjustment for hypertension was made, there was no measurement of blood pressure variability, a proxy for vessel stiffness, which may be important in driving atherosclerosis and may cause elevation in NT-proBNP through increasing cardiac workload. 3 Previous studies have shown that brain atrophy and cognitive impairment are associated with cardiac failure, 4 symptomatic coronary vascular disease, 5 and both symptomatic and asymptomatic carotid stenoses, although not all have found relationships with CIMT. 6 The current study is important in showing the prognostic value of baseline markers of cardiac and carotid diseases in a community-based sample in which rates of symptomatic vascular disease were low (18.5% coronary heart disease and 4.6% stroke).
The authors discuss possible mechanisms for the observed associations between brain atrophy and cardiac and carotid diseases. The relationship between cerebral perfusion and brain health is well established: low cardiac output results in selective neuronal death and brain atrophy, and low cerebral perfusion has been implicated in the development of white matter disease and neurodegeneration. Although autoregulation acts to maintain a constant cerebral blood flow, this may be challenged by sudden change in systemic pressure, end-stage cardiac failure, or severe extra or intracranial atherosclerosis. However, it is unlikely that cardiac dysfunction and carotid disease severe enough to affect cerebral perfusion can explain all the observed associations in this study of communitydwelling volunteer subjects. Rates of symptomatic vascular disease were low, and associations remained after exclusion of those with previous stroke. As stated by the authors, high NT-proBNP and CIMT might reflect a global systemic vascular condition affecting the small and larger vessels. Indeed, higher NT-proBNP levels have been shown to associate with retinal microvascular disease 7 and with subcortical vascular dementia. 8 The lack of a relationship between white matter volume loss and NT-proBNP/CIMT in the current study is, therefore, perhaps unexpected, but small-vessel disease damage might have been better detected using more sensitive magnetic resonance measures of white matter lesion load or white matter tract disruption. Genetic factors may mediate some of the shared susceptibility to cardiovascular disease and cognitive decline: genetic polymorphisms have recently been shown to increase the risk of both vascular disease (stroke) and Alzheimer dementia. 9 Also, reverse causation may play a role in increasing NT-proBNP levels through loss of neurohumeral and physiological (eg, blood pressure) homeostasis caused by the failing brain.
Associations between brain atrophy and NT-proBNP and CIMT might also be mediated by inflammatory processes: reciprocal relationships exist between cardiac disease, atherosclerosis, blood pressure variability, and inflammation. 3 In addition, although NT-proBNP is characteristically associated with cardiac dysfunction, high levels are also seen in proinflammatory conditions including acute arthritis, cancer, renal failure, and sepsis in which it is an independent predictor of mortality. 10 Inflammatory mediators influence brain microglia, possibly potentiating neurodegeneration and blood-brain barrier dysfunction, 11 and NT-proBNP levels are predictive of cognitive decline in healthy individuals independent of vascular or Alzheimer risk factors. 12 Systemic inflammation linked to ageing, obesity, diabetes mellitus, and hypertension has
